PerkinElmerStock Price and Value Analysis

Should you buy PerkinElmer stock? (NYSE:PKI). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company has stable growth.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.

PKI Free Cash Flow Trend

Based on historical returns, we believe that PerkinElmer can grow its free cash at a rate of about 3%. That's positive!

Free Cash Flow trendline for PKI
Free Cash Flow trendline for PerkinElmer

Inside the PKI Numbers

PKI Price
(PerkinElmer stock price per share)
$71.03
[?] PKI Fair Price
(based on intrinsic value)
$41.26
[?] PKI Safety Price (based on a variable margin of safety) $33.01
[?] PE Ratio versus Sector 3% lower than other Healthcare stocks
[?] PE Ratio versus Industry 90% lower than other Medical Laboratories & Research stocks
[?] Cash Yield 4.72%
[?] Free Cash Flow Jitter 15%
[?] Dividend Yield 0%

Is PerkinElmer Stock on Sale?

We believe that PerkinElmer may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

PerkinElmer looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy PKI Stock?

Does PerkinElmer have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.